PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 ...
Edgewise Therapeutics Announces Positive Topline Results from CANYON Phase 2 Trial of Sevasemten in Individuals with Becker ...
Catch up on PPMD Together: Virtual Edition – A Gathering of Families for Connection, Support, and Growth ...